Bausch Health Companies Inc
BHCBausch Health Companies Inc. is a global pharmaceutical company specializing in the development, manufacturing, and marketing of a broad range of healthcare products, including prescription medications, over-the-counter products, and medical devices. Founded in 2010 and headquartered in Laval, Quebec, Bausch Health focuses on areas such as eye health, dermatology, gastrointestinal, and neurology, aiming to improve patient outcomes through innovative therapies.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 22, 2010 | $1.00 | 2010-11-10 | 2010-11-15 |
| October 4, 2010 | $0.10 | 2010-08-30 | 2010-09-01 |
| July 5, 2010 | $0.10 | 2010-05-28 | 2010-06-02 |
| April 5, 2010 | $0.09 | 2010-03-04 | 2010-03-08 |
| January 4, 2010 | $0.09 | 2009-11-30 | 2009-12-02 |
Dividends Summary
- Bausch Health Companies Inc has issued 22 dividend payments over the past 5 years
- The most recent dividend was paid 5465 days ago, on December 22, 2010
- The highest dividend payed out to investors during this period was $1.00 per share
- The average dividend paid during this period was $0.29 per share.
Company News
The global ophthalmic drugs market is projected to grow from USD 37.35 billion in 2023 to USD 62.74 billion by 2032, driven by increasing eye disorders, advanced drug delivery methods, and rising healthcare awareness.
Bausch Health Companies' stock rose 11% after acquiring Wuhan Shibo Zhenmei Technology, a distributor of its aesthetic products in China, which enhances its market presence in the region.
The article highlights five stocks trading under $10 that show potential for significant price appreciation, driven by factors like user growth, economic recovery, and strategic improvements in their respective industries.
A new AGA-sponsored survey reveals that IBS symptoms continue to significantly disrupt patients' daily lives, with symptoms interfering with work and personal activities for nearly 19 days per month, despite increased awareness and treatment advancements.
Bausch's (BHC) first-quarter earnings and sales miss their respective estimates. Its shares fall in response to the results.
